Antitumor vaccination in patients with head and neck squamous cell carcinomas with autologous virus-modified tumor cells

Prognosis of patients with advanced head and neck squamous cell carcinomas (HNSCC) is still poor. Therefore, we analyzed whether antitumor vaccination with a virus-modified autologous tumor cell vaccine is feasible and safe in HNSCC patients. Furthermore, we determined the influence on disease-free...

Full description

Saved in:

Bibliographic Details
Published in:	Cancer research (Chicago, Ill.) Vol. 64; no. 21; pp. 8057 - 8061
Main Authors:	KARCHER, Jochen, DYCKHOFF, Gerhard, BECKHOVE, Philipp, REISSER, Christoph, BRYSCH, Michael, ZIOUTA, Yvonne, HELMKE, Burkhard H, WEIDAUER, Hagen, SCHIRRMACHER, Volker, HEROLD-MENDE, Christel
Format:	Journal Article
Language:	English
Published:	Philadelphia, PA American Association for Cancer Research 01-11-2004
Subjects:	Adult Aged Antineoplastic agents Biological and medical sciences Cancer Vaccines - immunology Carcinoma, Squamous Cell - therapy Female Head and Neck Neoplasms - therapy Humans Hypersensitivity, Delayed - etiology Male Medical sciences Middle Aged Newcastle disease virus Newcastle disease virus - immunology Pharmacology. Drug treatments Pilot Projects T-Lymphocytes - immunology Tumors Vaccination Antineoplastic agent Human Prevention Virus Vaccination ENT disease Head and neck squamous cell carcinoma Autologous system Malignant tumor Tumor cell
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!